Novavax
NVAX
#5215
Rank
S$1.45 B
Marketcap
$9.05
Share price
6.97%
Change (1 day)
51.62%
Change (1 year)

Revenue for Novavax (NVAX)

Revenue in 2024 (TTM): S$0.91 Billion

According to Novavax's latest financial reports the company's current revenue (TTM ) is S$0.91 Billion. an increase over the revenue in the year 2023 that were of S$0.91 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 1996 to 2024

20002005201020152020$0.5B$1B$1.5B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 S$0.92 B1.24%
2023 S$0.91 B-50.97%
2022 S$1.86 B20.54%
2021 S$1.54 B146.3%
2020 S$0.62 B2400.77%
2019 S$25.15 M-46.29%
2018 S$46.84 M12.34%
2017 S$41.69 M87.66%
2016 S$22.22 M-56.67%
2015 S$51.27 M26.58%
2014 S$40.51 M52.89%
2013 S$26.49 M-1.85%
2012 S$26.99 M41.93%
2011 S$19.02 M4205.25%
2010 S$0.44 M-3.17%
2009 S$0.45 M-70.01%
2008 S$1.52 M-18.97%
2007 S$1.87 M-73.85%
2006 S$7.18 M-41.62%
2005 S$12.3 M-15.51%
2004 S$14.55 M-27.3%
2003 S$20.02 M-18.75%
2002 S$24.64 M-44.68%
2001 S$44.55 M938.59%
2000 S$4.28 M114.69%
1999 S$1.99 M72.88%
1998 S$1.15 M14.24%
1997 S$1.01 M140.94%
1996 S$0.41 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$0.13 B-84.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.54 B 178.82%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.35 B 48.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.60 B-33.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$72.49 B 7,826.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$85.30 B 9,227.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$69.34 B 7,482.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$53.87 B 5,790.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$9.41 M-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA